As the incidence of diabetes continues to increase in the western world, the prevalence of chronic wounds related to this condition continues to be a major focus of wound care research. Additionally, over 50% of chronic wounds exhibit signs and symptoms that are consistent with localized bacterial biofilms underlying severe infections that contribute to tissue destruction, delayed wound-healing and other serious complications. Most current biomedical approaches for advanced wound care aim at providing antimicrobial protection to the open wound together with a matrix scaffold (often collagen-based) to boost reestablishment of the skin tissue. Therefore, the present review is focused on the efforts that have been made over the past years to find peptides possessing wound-healing properties, towards the development of new and effective wound care treatments for diabetic foot ulcers and other skin and soft tissue infections.
CITATION STYLE
Gomes, A., Teixeira, C., Ferraz, R., Prudencio, C., & Gomes, P. (2017, October 1). Wound-healing peptides for treatment of chronic diabetic foot ulcers and other infected skin injuries. Molecules. MDPI AG. https://doi.org/10.3390/molecules22101743
Mendeley helps you to discover research relevant for your work.